Viewing Study NCT04539366


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2025-12-24 @ 4:11 PM
Study NCT ID: NCT04539366
Status: SUSPENDED
Last Update Posted: 2025-11-03
First Post: 2020-09-04
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module